ELECTROPHYSIOLOGIC AND ANTIFIBRILLATORY ACTIVITY OF UK-68798, A CLASS-III ANTIARRHYTHMIC AGENT

被引：0

作者：

BLACK, SC ^{[1
]}

CHI, L ^{[1
]}

MU, DX ^{[1
]}

LUCCHESI, BR ^{[1
]}

机构：

[1] UNIV MICHIGAN,SCH MED,ANN ARBOR,MI 48109

来源：

FASEB JOURNAL | 1991年 / 5卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A1215 / A1215

页数：1

共 50 条

[11] IS IT PRACTICAL TO DEVELOP A CLASS-III ANTIARRHYTHMIC AGENT
AGERSBORG, HPK
LATTS, J
RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 157 - 166
[12] EFFECTS OF WAY-123,398, A NEW CLASS-III ANTIARRHYTHMIC AGENT, ON CARDIAC REFRACTORINESS AND VENTRICULAR-FIBRILLATION THRESHOLD IN ANESTHETIZED DOGS - A COMPARISON WITH UK-68798, E-4031, AND DL-SOTALOL
SPINELLI, W
PARSONS, RW
COLATSKY, TJ
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (06) : 913 - 922
[13] DOFETILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT
RASMUSSEN, HS
ALLEN, MJ
BLACKBURN, KJ
BUTROUS, GS
DALRYMPLE, HW
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S96 - S105
[14] ELECTROPHYSIOLOGIC ACTIVITY AND ANTIARRHYTHMIC EFFICACY OF CK-3579, A NEW CLASS-III ANTIARRHYTHMIC AGENT WITH BETA-ADRENERGIC BLOCKING PROPERTIES
ARGENTIERI, TM
TROY, HH
CARROLL, MS
DOROSHUK, CM
SULLIVAN, ME
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (04) : 647 - 655
[15] ANTIFIBRILLATORY EFFECTS OF CLASS-III ANTIARRHYTHMIC DRUGS - COMPARATIVE-STUDY WITH FLECAINIDE
USUI, M
INOUE, H
SAIHARA, S
SUGIMOTO, T
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (03) : 376 - 383
[16] FOCUS ON DOFETILIDE - A SELECTIVE CLASS-III ANTIARRHYTHMIC AGENT
TRAN, HT
KLUGER, J
CHOW, MSS
HOSPITAL FORMULARY, 1995, 30 (01): : 23 - 27
[17] PHARMACOLOGY OF SEMATILIDE, A NONQUATERNARY CLASS-III ANTIARRHYTHMIC AGENT
GREENBERG, SS
LUISI, A
LONG, JP
WILLIAMSON, HE
DRUG DEVELOPMENT RESEARCH, 1992, 25 (04) : 283 - 302
[18] FOCUS ON SOTALOL - A CLASS-III ANTIARRHYTHMIC AGENT WITH BETA-BLOCKING ACTIVITY
PHARAND, C
CHOW, MSS
HOSPITAL FORMULARY, 1992, 27 (11): : 1094 - &
[19] ELECTROPHYSIOLOGIC EFFECTS OF E-4031, A NEW CLASS-III ANTIARRHYTHMIC AGENT, IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS
ISOMOTO, S
SHIMIZU, A
KONOE, A
KAIBARA, M
CENTURION, OA
FUKATANI, M
YANO, K
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (16) : 1464 - 1467
[20] ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS E-4031, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS
FUJIKI, A
TANI, M
MIZUMAKI, K
SHIMONO, M
INOUE, H
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (03) : 374 - 378

← 1 2 3 4 5 →